S14G-humanin (HNG) ameliorates diabetic nephropathy tubular injury by inhibiting Z-DNA/ZBP1-mediated necroptosis.
文献摘要
Background Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, with limited therapeutic options. S14G-humanin (HNG), a potent analog of humanin, exerts protective effects in various diseases, but its role in DN remains unexplored. Methods DN was induced in C57BL/6 mice via high-fat diet and streptozotocin (STZ), with or without HNG treatment. Renal injury, necroptosis, and Z-DNA/ZBP1 pathways were evaluated by histology, western blotting, and transcriptomics, and key findings were validated in db/db mice and high glucose/palmitate (HG + PA)-treated HK-2 cells. Results HNG treatment dose-dependently alleviated renal injury in DN mice. Specifically, high-dose-HNG significantly reduced the urinary albumin-to-creatinine ratio (UACR) by 49.5% (from 103.91 ± 7.68 to 52.50 ± 4.02 μg/mg, P Conclusion HNG ameliorates DN tubular injury by inhibiting BAX-driven mitochondrial oxidative stress and subsequent Z-DNA/ZBP1-mediated necroptosis, highlighting HNG as a promising therapeutic candidate for DN.